Turning evidence into impact

Cutting through the noise to turn complex landscapes and evidence into high-impact value strategies – bridging clinical promise and reimbursement reality.

Connect with our Experts

How we can support

From low disease awareness and surrogate endpoints, to complex competitive environments – standard approaches often fall short in delivering full value recognition.

Demonstrating benefit to patients and healthcare systems is fundamental to launch success. We believe changing perception requires impactful framing and clarity in communication.

At Prescient, we help our clients cut through the noise to turn complex landscapes and evidence into high-impact value strategies – bridging clinical promise and reimbursement reality.


Our Value services


The numbers

Extensive experience

0

+ Projects delivered

Diverse expertise

0

+ Indications in rare & oncology

Proven track record

0

+ Products supported

News and Insights

Explore our latest insights, whitepapers, and event highlights to learn more about the latest developments and perspectives shaping the evolving healthcare landscape.

Discover all
Whitepaper

The transformative value of cancer medicines in Europe  

Find out more
Whitepaper

Facilitating effective health technology assessment for gene therapies

Find out more
Blog

Evolution of willingness to pay in cost-effectiveness countries United Kingdom, Australia, Canada and Sweden

Find out more
Event

Recommendations for better use of quality of life evidence in HTA for rare diseases

Find out more
Blog

Absence of comparative survival data in health technology assessment of oncology therapies

Find out more

Want to understand how we can optimize your value strategy and communication?

If you’re interested in learning more about our services or would like to speak with the team, please get in touch.

Connect with our experts